These products include select botanical preparations and technology related to botanical therapeutics, the Mound Development Corp. said in a release.
MORE: This Kettering company is looking for hundreds of workers right now
“This expansion into Miamisburg will include a research facility where Bluegrass will continue to develop transformative technology in the botanical phytotherapeutics space including nanotherapies, microencapsulation, and heterocyclic photocatalysis,” the corporation said.
“We needed a well-equipped and conveniently located laboratory to conduct our basic research,” Jon Tumey, Bluegrass chief technology officer, said in Mound’s announcement. “We found the Mound met all our immediate needs including a perfectly sized space and all the basic essentials already available.”
Bluegrass Farmaceuticals, LLC will occupy a former laboratory in Suite 316 at 965 Capstone Drive.
“This is a good example of what only the Mound can offer potential tenants,” Mound Business Park President Eric Cluxton said. “Several of our available properties come with industry-specific infrastructure already in place, offering convenience and significant cost-savings to our new tenants.”
The business park used to be a federal development facility for nuclear weapons research, fuel and components.
The site employed as many as 1,800 people as late as 1991.
Then, during the first George Bush administration, the government decided to close the facility, dealing an economic blow to the region.
Since then, Mound has been engaged in a gradual transition from a Cold War facility to a private business park, with years of environmental clean-up and marketing to win commercial tenants.
The site is prized for its privacy and the durability of its infrastructure.
About the Author
